- In May 2025, Waters Corporation acquired Halo Labs, an innovator of specialized imaging technologies for detecting and identifying interfering materials in therapeutic products. This acquisition integrates Halo Labs' Aura platform, which performs full-spectrum particle analysis, complementing Waters' existing light scattering detection solutions. This move enhances Waters' offerings in large molecule development and quality assurance/quality control (QA/QC), particularly for emerging biopharma therapies such as CAR T-cell therapies
- In April 2025, Revvity Signals Software, a division of Revvity, Inc., launched its Signals One platform. This unified software platform, evolved from the company's existing research portfolio, is designed to streamline data management across the entire drug discovery lifecycle. It addresses the growing complexity of drug modalities research by integrating advanced research capabilities and fostering collaboration in multidisciplinary workflows
- In March 2025, LabWare, a global leader in LIMS, unveiled new additions to its SaaS portfolio, including LabWare ASSURE, LabWare QAQC, and LabWare GROW. These offerings aim to redefine how laboratories integrate LIMS, providing instant access to scalable, ready-to-use enterprise configurations. This expansion focuses on reducing deployment risk and accelerating time-to-go-live, making high-quality informatics solutions accessible to both startups and global enterprises with OpEx-based pricing
- In February 2025, Agilent Technologies and ABB Robotics announced a cooperation agreement to deliver advanced laboratory automation solutions. This collaboration combines Agilent's cutting-edge analytical technologies and laboratory software with ABB's state-of-the-art robotics
- In February 2024, LabVantage Solutions announced significant growth in its Professional Services Organization, expanding globally to reduce implementation timelines for customers. Concurrently, LabVantage introduced a "Digitally Native Ecosystem" aimed at boosting speed and success in R&D laboratories, emphasizing how the strategic integration of AI and automation is reshaping lab operations for faster, more accurate diagnostic insights
